Literature DB >> 30056735

Advance care planning in metastatic breast cancer.

Junji Matsuoka1, Toshiki Kunitomi2, Masahiko Nishizaki2, Takayuki Iwamoto2, Hideki Katayama2.   

Abstract

End-of-life care requires improvement. For a good death, patients consider five factors important: managing physical symptoms, avoiding a useless prolongation of dying, having good self-esteem, relieving burdens on the family, and deepening ties with loved ones. Four out of those 5 are accomplished by the implementation of advance care planning (ACP). ACP is not simply a formal writing of a patient's preferences about end-of-life treatment, but it is a process of communication between a patient, their family and care providers. There are few studies on ACP for patients with metastatic breast cancer. However, data on seriously ill patients support ACP's favorable effects on end of life care outcomes for not only patients, but family members and care providers as well. The observed keys to success for ACP were trained facilitators, education of the medical staff, inclusion of family and surrogate members, and a system to support ACP. ACP should be regarded as a standard of care to improve the quality of life of patients with metastatic breast cancer.

Entities:  

Keywords:  Advance care planning (ACP); advance directive (AD); breast cancer; end of life; end-of-life care; geriatric oncology; medical education; metastatic breast cancer (mBC); palliative care

Mesh:

Year:  2018        PMID: 30056735     DOI: 10.21037/cco.2018.06.03

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  2 in total

1.  Circulating miRNAs as early indicators of diet and physical activity response in women with metastatic breast cancer.

Authors:  Jessica Olson; Patricia Sheean; Lauren Matthews; Christopher R Chitambar; Anjishnu Banerjee; Alexis Visotcky; Marcelo Bonini; Melinda Stolley
Journal:  Future Sci OA       Date:  2021-03-04

2.  Gynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention.

Authors:  Sarah P Huepenbecker; Sophia Lewis; Mark C Valentine; Marguerite L Palisoul; Premal H Thaker; Andrea R Hagemann; Carolyn K McCourt; Katherine C Fuh; Matthew A Powell; David G Mutch; Lindsay M Kuroki
Journal:  Gynecol Oncol Rep       Date:  2022-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.